Condition
Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
Estimated Enrollment: 55
Age Group: Child, Adult, Senior
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: NCI-2012-02466|SWOG-S0218|U10CA032102|CDR0000069360
Study First Received: June 6, 2002
Last Updated: January 23, 2013
Estimated Primary Completion Date: June 2007
Primary Outcome Measures:
Overall survival rate|RECIST response rate|Association between EGFR expression with survival and response
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00039182
